Latest news
‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 14:12:01 GMTPfizer unveils additional $2.5B in planned cost savings through 2029 - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 15:33:48 GMTPfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 12:47:33 GMTPfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMT